It’s a slow news day so I will take this opportunity to talk about my latest asymmetric bet: biotech stocks. The hottest sector today is AI. It’s great but I feel people seem to ignore the biotech/genomic revolution we are experiencing right now. Remember the ground breaking CRISPR technology, the increasingly affordable and advanced genomic sequencing, single cell transcriptomics, computational biology, etc etc? People talked about all these back in 2020/2021 when the biotech stocks were overhyped but now after the biotech stocks crashed 70%, the narrative wanes. But the biotech sector is actually still advancing at a very rapid speed and we might be seeing the first CRISPR based therapy that cures sickle cell disease get approved by the FDA by the end of the year. (It’s a collaboration of CRISPR Therapeutics and Vertex Bio.) What an exciting time we live in! I am no biotech expert but I can see once the CRISPR based therapy gets approved, people are going to get excited about biotech again. I bought some CRSP 0.00%↑ shares at ~$50 and will be patiently waiting for the FDA approval decision. If the therapy doesn’t get approved, the company still has a lot of other therapies in the pipeline. If it does get approved, it will open a flood gate of CRISPR based gene therapies and its impact could be as significant as Generative AI.
Comments
No posts